Immunogenicity of Influenza Vaccinations

NCT06518577 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

605

Enrollment

OTHER

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Flucelvax (ccIIV4)
BIOLOGICAL: Flublok (RIV) or Fluzone (IIV)

Sponsor

Duke University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]